Medidata Solutions (NAS: MDSO) reported earnings on Oct. 31. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Medidata Solutions met expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP earnings per share dropped significantly.
Gross margins grew, operating margins dropped, net margins shrank.
Medidata Solutions notched revenue of $55.8 million. The seven analysts polled by S&P Capital IQ expected to see revenue of $56.1 million on the same basis. GAAP reported sales were 21% higher than the prior-year quarter's $46.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.16. The four earnings estimates compiled by S&P Capital IQ anticipated $0.23 per share. GAAP EPS of $0.16 for Q3 were 48% lower than the prior-year quarter's $0.31 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 71.5%, 70 basis points better than the prior-year quarter. Operating margin was 12.2%, 410 basis points worse than the prior-year quarter. Net margin was 7.3%, 890 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $58.3 million. On the bottom line, the average EPS estimate is $0.27.
Next year's average estimate for revenue is $218.3 million. The average EPS estimate is $0.79.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 48 members out of 51 rating the stock outperform, and three members rating it underperform. Among 13 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 13 give Medidata Solutions a green thumbs-up, and give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Medidata Solutions is outperform, with an average price target of $39.17.
Add Medidata Solutions to My Watchlist.
The article Medidata Solutions Meets on Revenues, Misses on EPS originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.